HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of 1 -testololactone (NSC-23759) and an estrogen-progestin combination (NSC-77622) in the treatment of metastatic breast cancer.

AuthorsR W Talley, R M O'Bryan, J H Burrows, E L San Diego
JournalCancer chemotherapy reports (Cancer Chemother Rep) Vol. 54 Issue 4 Pg. 249-53 (Aug 1970) ISSN: 0069-0112 [Print] United States
PMID4946009 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Drug Combinations
  • Hydroxyprogesterones
  • Lactones
  • Phenanthrenes
  • Estradiol
  • Testolactone
Topics
  • Antineoplastic Agents (therapeutic use)
  • Breast Neoplasms (drug therapy)
  • Clinical Trials as Topic
  • Drug Combinations
  • Estradiol (therapeutic use)
  • Female
  • Humans
  • Hydroxyprogesterones (therapeutic use)
  • Lactones (therapeutic use)
  • Neoplasm Metastasis
  • Phenanthrenes (therapeutic use)
  • Testolactone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: